Navigation Links
myMatrixx Launches myRisk Predictor™ a Patent-Pending Risk Assessment Tool
Date:11/29/2011

TAMPA, Fla., Nov. 29, 2011 /PRNewswire/ -- myMatrixx®, a full-service pharmacy and ancillary medical benefits management company, announced today the release of myRisk Predictor™ a patent-pending revolutionary risk assessment tool designed to identify injured workers who are at high risk for potential abuse and misuse of prescription medications. myRisk Predictor combines predictive modeling with historical data and unique algorithms developed by the myMatrixx clinical team to develop a customized risk score for injured workers. This real-time tool alerts insurance carriers, third party administrators and self-insured entities when claimants within their populations may be in need of intervention.

(Logo: http://photos.prnewswire.com/prnh/20111005/FL81065LOGO)

"Claims adjusters are typically managing so many cases that there is little time to analyze risk associated with the medications prescribed to injured workers," stated Phil Walls, R. Ph., Chief Clinical & Compliance Officer with myMatrixx. "Additionally with alarming increases in the rates of drug costs, fraud and abuse, our clients are seeking intervention before a case may spiral out of control. This tool enhances our current processes," added Walls.

Since the perception of risk varies between populations, myRisk Predictor allows clients to uniquely assign different weights based on their specific needs. Once individuals are identified using myRisk Predictor, myMatrixx's clinical team can provide a complete drug regimen review, peer-to-peer intervention with the treating physician and assist with developing an alternative treatment plan. By identifying and treating individuals at risk earlier in the claims process, myMatrixx aims to lower the costs of care and improve outcomes for injured workers, contributing to the companies "Get Ahead of the Claim" program.

For more information on myRisk Predictor, please contact Lori Taylor, Director of Marketing and Communications, at (813) 321-1317.

About myMatrixx

myMatrixx is a full-service pharmacy and ancillary medical benefits management company focusing on the workers' compensation market. By combining advanced technology, clinical expertise and comprehensive reporting, myMatrixx simplifies the management of claims. Our results driven solutions deliver reduced costs for our clients and improve outcomes for their injured workers. For more information, visit www.mymatrixx.com.

Contact:

Lori Taylor, Director of Marketing and Communications

 

(877) 804-4900, ext 136 or ltaylor@mymatrixx.com


'/>"/>
SOURCE myMatrixx
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. myMatrixxs Phil Walls, R.Ph. Receives National and Regional Recognition
2. ForteBio Launches Dip and Read™ Anti-GST Biosensor
3. Henry Schein Dental Launches Total Health™ Beyond the Mouth
4. U-Systems Launches somo-v Platinum Automated Breast Ultrasound System at RSNA
5. Alacrita Launches Charity Auction of Executive One-to One Lunches with Senior Figures from the Pharmaceutical and Venture Capital Industries
6. MedVantx Launches Patient Profile™, A Proprietary Closed-Loop Pharmaceutical Adherence Management Program for Medical Home, Accountable Care and Population Health Management
7. MedSolutions Launches Implantable Cardiac Defibrillator Program to Reduce Unnecessary Surgeries
8. Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization
9. Prime Therapeutics Launches Retail Medication Therapy Management Program
10. Codman Launches CERTAS™ Programmable Valve for Hydrocephalus
11. HeartSine® Technologies Launches New Global Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)... 2017 ... coming to Washington DC ... Tuesday, September 12 th – Monday, September 18 th .The Brain ... MRI brain scans to the public.Where:  BTF,s Mobile ... 501 K Street NW, Washington, D.C.What:BTF brings its nationwide initiative, the Road ...
(Date:9/9/2017)... 9, 2017  Eli Lilly and Company (NYSE: ... endpoint data for lasmiditan, an investigational, oral, first-in-class molecule ... significant improvements compared to placebo in the Phase 3 ... the 18th Congress of the International Headache Society (IHC) ... data presented today demonstrate lasmiditan,s potential to reduce pain ...
(Date:9/7/2017)... -- For nearly two decades, New Life Agency has been committed to providing ... New Life Agency announces a powerful three-way partnership designed to deliver substantial ... ... http://www.schrafts2.com/ ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
Breaking Medicine Technology:
(Date:9/25/2017)... ... September 25, 2017 , ... ... technology-enabled services supporting clinical research, today announces that 30 of its domain ... the drug development lifecycle at upcoming industry conferences and webinars. Drawing on ...
(Date:9/25/2017)... ... September 25, 2017 , ... Earlypicker is expanding its offerings ... shop for the hottest Korean cosmetics and fashion trends sweeping the nation. The decision ... already well-known for the great offerings that allow Koreans everywhere to look their best ...
(Date:9/25/2017)... , ... September 25, 2017 , ... “The Majestic Unicorn”: ... the great flood. “The Majestic Unicorn” is the creation of published author, Dayna Chantel, ... small, came from far and wide to march aboard the cypress ark-vessel. Male and ...
(Date:9/25/2017)... Philadelphia, PA (PRWEB) , ... September 25, 2017 , ... Emerald Ash Borers ... pest's destruction can be seen throughout the Philadelphia region. A video by Rob Nagy, ... is lined with Ash trees. While several are dead or showing signs of decline ...
(Date:9/24/2017)... ... ... Throughout the United States and the world, clinicians take a simple but ... providers work to give the best care possible to patients and communities, while seeking ... are threatening to tie our hands in carrying out that oath. The Graham-Cassidy legislation ...
Breaking Medicine News(10 mins):